Finally, electroanatomical mapping and ablation of the trigger PVC were successfully performed.<h4>Conclusion</h4>in patients with recurrent VF episodes despite evidence-based medical treatment for myocarditis, MVP should be considered as an alternative arrhythmogenic substrate, and warrants early ICD implant and PVC-targeted therapy. This evidence concerns the gene MVP and myocarditis.